 | • レポートコード：GIR-105X17983 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、腫瘍壊死因子（TNF）阻害薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。腫瘍壊死因子（TNF）阻害薬の種類別市場規模（レミケード、フミラ、シムジア、シンポニー、その他）、用途別市場規模（オンライン薬局、専門薬局、病院薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・腫瘍壊死因子（TNF）阻害薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Takeda Pharmaceuticals、Amgen、AbbVie、Pfizer、Novartis、Johnson and Johnson、UCB、Merck、Abbott Laboratories、Biogen、Gilead Sciences、Thermo Fisher Scientific、Bristol-Myers Squibb、Astellas Pharma、AstraZeneca、Eli Lilly and Company、Roche、Sanofi ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：レミケード、フミラ、シムジア、シンポニー、その他 ・用途別分析2016年-2026年：オンライン薬局、専門薬局、病院薬局 ・腫瘍壊死因子（TNF）阻害薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・腫瘍壊死因子（TNF）阻害薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・腫瘍壊死因子（TNF）阻害薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・腫瘍壊死因子（TNF）阻害薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・腫瘍壊死因子（TNF）阻害薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Tumor Necrosis Factor (TNF) Inhibitor Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Tumor Necrosis Factor (TNF) Inhibitor Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Tumor Necrosis Factor (TNF) Inhibitor Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Tumor Necrosis Factor (TNF) Inhibitor Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Remicade
Humira
Cimzia
Simponi
Others
Market segment by Application can be divided into
Online Pharmacies
Specialty Pharmacies
Hospital Pharmacies
The key market players for global Tumor Necrosis Factor (TNF) Inhibitor Drugs market are listed below:
Takeda Pharmaceuticals
Amgen
AbbVie
Pfizer
Novartis
Johnson and Johnson
UCB
Merck
Abbott Laboratories
Biogen
Gilead Sciences
Thermo Fisher Scientific
Bristol-Myers Squibb
Astellas Pharma
AstraZeneca
Eli Lilly and Company
Roche
Sanofi
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Tumor Necrosis Factor (TNF) Inhibitor Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Remicade
1.2.3 Humira
1.2.4 Cimzia
1.2.5 Simponi
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Online Pharmacies
1.3.3 Specialty Pharmacies
1.3.4 Hospital Pharmacies
1.4 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size & Forecast
1.4.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales in Value (2016-2026))
1.4.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales in Volume (2016-2026)
1.4.3 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Price by Type (2016-2026) & (USD/MT)
1.5 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Production Capacity Analysis
1.5.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Total Production Capacity (2016-2026)
1.5.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Drivers
1.6.2 Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Restraints
1.6.3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Takeda Pharmaceuticals
2.1.1 Takeda Pharmaceuticals Details
2.1.2 Takeda Pharmaceuticals Major Business
2.1.3 Takeda Pharmaceuticals Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
2.1.4 Takeda Pharmaceuticals Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
2.2.4 Amgen Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
2.3.4 AbbVie Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
2.4.4 Pfizer Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
2.5.4 Novartis Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Johnson and Johnson
2.6.1 Johnson and Johnson Details
2.6.2 Johnson and Johnson Major Business
2.6.3 Johnson and Johnson Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
2.6.4 Johnson and Johnson Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 UCB
2.7.1 UCB Details
2.7.2 UCB Major Business
2.7.3 UCB Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
2.7.4 UCB Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
2.8.4 Merck Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Abbott Laboratories
2.9.1 Abbott Laboratories Details
2.9.2 Abbott Laboratories Major Business
2.9.3 Abbott Laboratories Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
2.9.4 Abbott Laboratories Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Biogen
2.10.1 Biogen Details
2.10.2 Biogen Major Business
2.10.3 Biogen Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
2.10.4 Biogen Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Gilead Sciences
2.11.1 Gilead Sciences Details
2.11.2 Gilead Sciences Major Business
2.11.3 Gilead Sciences Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
2.11.4 Gilead Sciences Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Thermo Fisher Scientific
2.12.1 Thermo Fisher Scientific Details
2.12.2 Thermo Fisher Scientific Major Business
2.12.3 Thermo Fisher Scientific Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
2.12.4 Thermo Fisher Scientific Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Bristol-Myers Squibb
2.13.1 Bristol-Myers Squibb Details
2.13.2 Bristol-Myers Squibb Major Business
2.13.3 Bristol-Myers Squibb Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
2.13.4 Bristol-Myers Squibb Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Astellas Pharma
2.14.1 Astellas Pharma Details
2.14.2 Astellas Pharma Major Business
2.14.3 Astellas Pharma Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
2.14.4 Astellas Pharma Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 AstraZeneca
2.15.1 AstraZeneca Details
2.15.2 AstraZeneca Major Business
2.15.3 AstraZeneca Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
2.15.4 AstraZeneca Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Eli Lilly and Company
2.16.1 Eli Lilly and Company Details
2.16.2 Eli Lilly and Company Major Business
2.16.3 Eli Lilly and Company Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
2.16.4 Eli Lilly and Company Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 Roche
2.17.1 Roche Details
2.17.2 Roche Major Business
2.17.3 Roche Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
2.17.4 Roche Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.18 Sanofi
2.18.1 Sanofi Details
2.18.2 Sanofi Major Business
2.18.3 Sanofi Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
2.18.4 Sanofi Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Manufacturer
3.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Tumor Necrosis Factor (TNF) Inhibitor Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Manufacturer Market Share
3.4.2 Top 6 Tumor Necrosis Factor (TNF) Inhibitor Drugs Manufacturer Market Share
3.5 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Tumor Necrosis Factor (TNF) Inhibitor Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Region
4.1.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Region (2016-2026)
4.2 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (2016-2026)
4.3 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (2016-2026)
4.4 Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (2016-2026)
4.5 South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (2016-2026)
4.6 Middle East and Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales in Volume by Type (2016-2026)
5.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Type (2016-2026)
5.3 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales in Volume by Application (2016-2026)
6.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Application (2016-2026)
6.3 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type (2016-2026)
7.2 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application (2016-2026)
7.3 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country
7.3.1 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type (2016-2026)
8.2 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application (2016-2026)
8.3 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country
8.3.1 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Region
9.3.1 Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type (2016-2026)
10.2 South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application (2016-2026)
10.3 South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country
10.3.1 South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country
11.3.1 Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Tumor Necrosis Factor (TNF) Inhibitor Drugs Typical Distributors
12.3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Pharmaceuticals Major Business
Table 5. Takeda Pharmaceuticals Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
Table 6. Takeda Pharmaceuticals Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Amgen Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Major Business
Table 9. Amgen Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
Table 10. Amgen Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. AbbVie Basic Information, Manufacturing Base and Competitors
Table 12. AbbVie Major Business
Table 13. AbbVie Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
Table 14. AbbVie Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
Table 18. Pfizer Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Major Business
Table 21. Novartis Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
Table 22. Novartis Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson and Johnson Major Business
Table 25. Johnson and Johnson Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
Table 26. Johnson and Johnson Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. UCB Basic Information, Manufacturing Base and Competitors
Table 28. UCB Major Business
Table 29. UCB Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
Table 30. UCB Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Merck Basic Information, Manufacturing Base and Competitors
Table 32. Merck Major Business
Table 33. Merck Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
Table 34. Merck Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 36. Abbott Laboratories Major Business
Table 37. Abbott Laboratories Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
Table 38. Abbott Laboratories Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Biogen Basic Information, Manufacturing Base and Competitors
Table 40. Biogen Major Business
Table 41. Biogen Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
Table 42. Biogen Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 44. Gilead Sciences Major Business
Table 45. Gilead Sciences Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
Table 46. Gilead Sciences Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 48. Thermo Fisher Scientific Major Business
Table 49. Thermo Fisher Scientific Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
Table 50. Thermo Fisher Scientific Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 52. Bristol-Myers Squibb Major Business
Table 53. Bristol-Myers Squibb Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
Table 54. Bristol-Myers Squibb Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 56. Astellas Pharma Major Business
Table 57. Astellas Pharma Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
Table 58. Astellas Pharma Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 60. AstraZeneca Major Business
Table 61. AstraZeneca Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
Table 62. AstraZeneca Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 64. Eli Lilly and Company Major Business
Table 65. Eli Lilly and Company Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
Table 66. Eli Lilly and Company Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Roche Basic Information, Manufacturing Base and Competitors
Table 68. Roche Major Business
Table 69. Roche Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
Table 70. Roche Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Sanofi Basic Information, Manufacturing Base and Competitors
Table 72. Sanofi Major Business
Table 73. Sanofi Tumor Necrosis Factor (TNF) Inhibitor Drugs Product and Services
Table 74. Sanofi Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Manufacturer (2019-2021e) & (MT)
Table 76. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 77. Market Position of Manufacturers in Tumor Necrosis Factor (TNF) Inhibitor Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 78. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Production Capacity by Company, (MT): 2020 VS 2021
Table 79. Head Office and Tumor Necrosis Factor (TNF) Inhibitor Drugs Production Site of Key Manufacturer
Table 80. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Region (2016-2021e) & (MT)
Table 81. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Region (2021-2026) & (MT)
Table 82. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 83. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Region (2021-2026) & (USD Million)
Table 84. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type (2016-2021e) & (MT)
Table 85. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type (2021-2026) & (MT)
Table 86. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 87. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Type (2021-2026) & (USD Million)
Table 88. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Price by Type (2016-2021e) & (USD/MT)
Table 89. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Price by Type (2021-2026) & (USD/MT)
Table 90. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application (2016-2021e) & (MT)
Table 91. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application (2021-2026) & (MT)
Table 92. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 93. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Application (2021-2026) & (USD Million)
Table 94. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Price by Application (2016-2021e) & (USD/MT)
Table 95. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Price by Application (2021-2026) & (USD/MT)
Table 96. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Country (2016-2021e) & (MT)
Table 97. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Country (2021-2026) & (MT)
Table 98. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 99. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Country (2021-2026) & (USD Million)
Table 100. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type (2016-2021e) & (MT)
Table 101. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type (2021-2026) & (MT)
Table 102. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application (2016-2021e) & (MT)
Table 103. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application (2021-2026) & (MT)
Table 104. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Country (2016-2021e) & (MT)
Table 105. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Country (2021-2026) & (MT)
Table 106. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 107. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Country (2021-2026) & (USD Million)
Table 108. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type (2016-2021e) & (MT)
Table 109. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type (2021-2026) & (MT)
Table 110. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application (2016-2021e) & (MT)
Table 111. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application (2021-2026) & (MT)
Table 112. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Region (2016-2021e) & (MT)
Table 113. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Region (2021-2026) & (MT)
Table 114. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 115. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Region (2021-2026) & (USD Million)
Table 116. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type (2016-2021e) & (MT)
Table 117. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type (2021-2026) & (MT)
Table 118. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application (2016-2021e) & (MT)
Table 119. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application (2021-2026) & (MT)
Table 120. South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Country (2016-2021e) & (MT)
Table 121. South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Country (2021-2026) & (MT)
Table 122. South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 123. South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Country (2021-2026) & (USD Million)
Table 124. South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type (2016-2021e) & (MT)
Table 125. South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type (2021-2026) & (MT)
Table 126. South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application (2016-2021e) & (MT)
Table 127. South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application (2021-2026) & (MT)
Table 128. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Country (2016-2021e) & (MT)
Table 129. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Country (2021-2026) & (MT)
Table 130. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 131. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Country (2021-2026) & (USD Million)
Table 132. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type (2016-2021e) & (MT)
Table 133. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Type (2021-2026) & (MT)
Table 134. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application (2016-2021e) & (MT)
Table 135. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Application (2021-2026) & (MT)
Table 136. Direct Channel Pros & Cons
Table 137. Indirect Channel Pros & Cons
Table 138. Tumor Necrosis Factor (TNF) Inhibitor Drugs Typical Distributors
Table 139. Tumor Necrosis Factor (TNF) Inhibitor Drugs Typical Customers
List of Figures
Figure 1. Tumor Necrosis Factor (TNF) Inhibitor Drugs Picture
Figure 2. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Type in 2020
Figure 3. Remicade
Figure 4. Humira
Figure 5. Cimzia
Figure 6. Simponi
Figure 7. Others
Figure 8. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Application in 2020
Figure 9. Online Pharmacies
Figure 10. Specialty Pharmacies
Figure 11. Hospital Pharmacies
Figure 12. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 13. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (2016-2026) & (MT)
Figure 34. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Production Capacity (2016-2026) & (MT)
Figure 35. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Drivers
Figure 37. Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Restraints
Figure 38. Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Trends
Figure 39. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Manufacturer in 2020
Figure 40. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share by Manufacturer in 2020
Figure 41. Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Tumor Necrosis Factor (TNF) Inhibitor Drugs Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Region (2016-2026)
Figure 45. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share by Region (2016-2026)
Figure 46. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (2016-2026) & (USD Million)
Figure 49. South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (2016-2026) & (USD Million)
Figure 51. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Type (2016-2026)
Figure 52. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share by Type (2016-2026)
Figure 53. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Price by Type (2016-2026) & (USD/MT)
Figure 54. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Application (2016-2026)
Figure 55. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share by Application (2016-2026)
Figure 56. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Price by Application (2016-2026) & (USD/MT)
Figure 57. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Country (2016-2026)
Figure 58. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share by Country (2016-2026)
Figure 59. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Type (2016-2026)
Figure 60. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Application (2016-2026)
Figure 61. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Country (2016-2026)
Figure 62. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share by Country (2016-2026)
Figure 63. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Type (2016-2026)
Figure 64. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Application (2016-2026)
Figure 69. South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Country (2016-2026)
Figure 70. South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share by Country (2016-2026)
Figure 71. South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Type (2016-2026)
Figure 72. South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
腫瘍壊死因子α阻害薬の世界市場2018-2025 The tumor necrosis factor alpha (TNF-a) inhibitors represent one of the major treatment methods for inflammatory diseases. Globally, this drug class is known to be the most successful drugs in the overall pharmaceutical industry. Several conditions such as inflammations, rheumatoid arthritis (RA), i…- 世界の免疫阻害剤市場 2021：企業別、地域別、種類・用途別 The Immune Anti-Inhibitor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 第VIII因子不足治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endotheli…
- 血友病治療薬の世界市場2018-2025 Hemophilia is a rare disorder in which your blood doesn't clot normally because it lacks sufficient blood-clotting proteins (clotting factors).In 2018, the global Hemophilia Treatment Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. I…
- 世界のSGLT2阻害剤市場 2021：企業別、地域別、種類・用途別 The SGLT2 Inhibitor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…